DarioHealth Corp. (NASDAQ:DRIO – Get Free Report)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.12 and traded as low as $0.78. DarioHealth shares last traded at $0.78, with a volume of 13,390 shares trading hands.
DarioHealth Price Performance
The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32. The firm has a market capitalization of $28.80 million, a price-to-earnings ratio of -0.86 and a beta of 1.51. The business’s fifty day simple moving average is $0.95 and its 200 day simple moving average is $1.12.
Institutional Investors Weigh In On DarioHealth
Hedge funds and other institutional investors have recently made changes to their positions in the business. Appian Way Asset Management LP grew its holdings in DarioHealth by 2.5% during the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after buying an additional 34,990 shares in the last quarter. DLK Investment Management LLC grew its stake in shares of DarioHealth by 71.6% in the 3rd quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after acquiring an additional 41,943 shares in the last quarter. Finally, XTX Topco Ltd grew its stake in shares of DarioHealth by 81.4% in the 3rd quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after acquiring an additional 13,219 shares in the last quarter. 33.39% of the stock is owned by institutional investors.
DarioHealth Company Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Read More
- Five stocks we like better than DarioHealth
- How to Evaluate a Stock Before Buying
- Tesla Investors Continue to Profit From the Trump Trade
- Investing in the High PE Growth Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How to Use the MarketBeat Dividend Calculator
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.